Researchers determined a short duration of anticoagulation therapy could be beneficial in comparison to a longer course for primary treatment VTE.

Anticoagulant: A medication that reduces blood’s ability to clot, thereby preventing thromboembolic events. Haemostasis: The physiological process that stops bleeding, involving blood clot ...

A Janelle Hermosillo, PharmD; Sarah A Spinler, PharmD FCCP BCPS (AQ Cardiology) Disclosures The Annals of Pharmacotherapy. 2008;42 (6):790-805.

Clinical Studies Evaluating the Combination of Aspirin, Thienopyridines, and Anticoagulants A total of 12 studies (1 case–control, 2 case series, 8 retrospective cohorts, 1 randomized open-label ...

Background and objective Prior studies have suggested that patients with premature ventricular complexes (PVCs) may have an ...

CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive ...

Bayer has decided to discontinue a phase 3 trial of its oral Factor XIa inhibitor asundexian in patients with atrial fibrillation (AF), after an interim analysis concluded the novel anticoagulant ...

Graphical AbstractThe prospective, multicenter, observational study (BAT2 [Bleeding With Antithrombotic Therapy Study-2]) enrolled patients receiving oral antiplatelets or anticoagulants from 52 ...

To avoid thrombotic complications, many have recommended prophylactic antithrombotic pharmacological therapies for COVID-19 patients, along with particular dosing instructions (34 – 37). However, to ...

The field of fibrinolytic enzymes and antithrombotic therapies has experienced rapid advances in recent years, with a growing focus on harnessing naturally occurring proteases for the targeted ...